{"schema_version":"secwatch.filing_event.v1","accession":"0001764013-25-000121","form_type":"8-K","ticker":"IMVT","cik":"0001764013","company_name":"Immunovant, Inc.","filed_at":"2025-07-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.915370+00:00","generated_at":"2026-05-17T23:46:18.413820+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Immunovant finalizes CEO Eric Venker's employment agreement with $672K salary, equity awards","bullets":["Annual base salary $672,000; target annual bonus 72.25% of base salary.","Option Awards: 1,300,000 stock options and options valued at $2,250,000 (189,900 shares), four-year vest.","CVAR Award: 1,475,000 capped appreciation rights with performance and $16.76 stock price hurdle.","Two-year holding period on vested shares from Unit Option Award and 87.25% of CVAR-settled shares.","Severance: 12 months salary + target bonus + COBRA if terminated without cause or for good reason."],"urls":{"canonical":"https://secwatch.observer/filing/0001764013-25-000121","json":"https://secwatch.observer/filing/0001764013-25-000121.json","markdown":"https://secwatch.observer/filing/0001764013-25-000121.md","text":"https://secwatch.observer/filing/0001764013-25-000121.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000121/0001764013-25-000121-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000121/imvt-20250728.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T23:46:18.413820+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}